Our Research

Please use selectors to filter reports

April 8, 2025
Unlisted Managed Investment

Wunala Capital Emerging Opportunities Fund – Research Review

The Wunala Capital Emerging Opportunities Fund provides exposure to unlisted and listed securities with a primary focus on providing investors exposure to private investment opportunities ...
Request professional access
April 7, 2025
Listed Managed Investment

Australian United Investment Company Ltd (ASX: AUI) Review

We have completed a review of AUI, which seeks to provide exposure to a diversified portfolio of ASX-listed companies with a focus on large and mid cap stocks and provide income and capital appreciation over the medium-to-long term. ...
Request professional access
March 24, 2025
Listed Managed Investment

Mirrabooka Investments Limited (ASX: MIR) Review

We have completed a review of MIR which seeks to deliver medium-to-long term gains, including an attractive fully franked dividend, through the investment in a diversified portfolio of Australian and New Zealand mid and small cap stocks. ...
Request professional access
March 24, 2025
Listed Managed Investment

Djerriwarrh Investments Limited (ASX: DJW) Review

We have completed a review of DJW, a LIC that seeks to provide a level of fully franked income that is higher than the S&P/ASX 200 Index. ...
Request professional access
March 24, 2025
Listed Managed Investment

AMCIL Limited (ASX: AMH) Review

We have completed a review of AMH, a LIC that seeks to deliver exposure to a concentrated portfolio of Australian and New Zealand listed securities that are likely to grow their earnings and dividends over the medium-and-long term....
Request professional access
March 24, 2025
Listed Managed Investment

Australian Foundation Investment Company Limited (ASX: AFI) Review

We have completed a review of AFI, one of the oldest listed investment companies (LICs) on the ASX with the Company listing in 1962. ...
Request professional access
March 20, 2025
Equity Research Coverage
U.S. Equities

Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) – Update Report

We have provided an update for Acurx following the release of the FY24 results and business update on 18 March 2025....
Request professional access
March 6, 2025
Newsletters
Newsletters & Thematics

IIR LMI Monthly Update

In this edition of the LMI monthly update we take a look at the recently completed LMI reviews as well as the key newsflow since the beginning of the year....
Request professional access
February 24, 2025
Listed Managed Investment

Argo Investments Limited (ASX: ARG) Review

ARG provides exposure to a highly diversified portfolio of ASX-listed securities with the objective of delivering long-term shareholder returns through reliable fully franked dividends and capital growth in a risk-controlled manner. ...
Request professional access